Llop-Guevara A, Vladimirova V, Schneeweiss A, Villacampa G, Karn T, Zahm DM, Herencia-Ropero A, Jank P, Van Mackelenbergh M, Fasching P, Marme F, Stickeler E, Schem C, Dienstmann R, Florian S, Nekljudova V, Balmana J, Denkert C, Loibl S, Serra V (2021)
Publication Type: Journal article, Original article
Publication year: 2021
Publisher: ELSEVIER
City/Town: AMSTERDAM
Pages Range: S22-S22
Conference Proceedings Title: ANNALS OF ONCOLOGY
DOI: 10.1016/j.annonc.2021.03.016
APA:
Llop-Guevara, A., Vladimirova, V., Schneeweiss, A., Villacampa, G., Karn, T., Zahm, D.-M.,... Serra, V. (2021). Association of RAD51 with homologous recombination deficiency (HRD) and clinical outcomes in untreated triple-negative breast cancer (TNBC): Analysis of the GeparSixto randomized clinical trial. Annals of Oncology, S22-S22. https://doi.org/10.1016/j.annonc.2021.03.016
MLA:
Llop-Guevara, A., et al. "Association of RAD51 with homologous recombination deficiency (HRD) and clinical outcomes in untreated triple-negative breast cancer (TNBC): Analysis of the GeparSixto randomized clinical trial." Annals of Oncology (2021): S22-S22.
BibTeX: Download